Related Experiment Video
Updated: Feb 1, 2026

Experimental Human Pneumococcal Carriage
Published on: February 15, 2013
[Bacteremic pneumococcal pneumonia in adults admitted to a general hospital. Experience in 60 cases]
María Luisa Rioseco Z1, Raúl Riquelme O1, Mauricio Riquelme O1
1Facultad de Medicina, Universidad San Sebastián, Patagonia, Chile.
Background:
Bacteremic pneumococcal pneumonia (BPP) is a preventable disease with high morbimortality.
Aim:
To evaluate clinical aspects and mortality on BPP patients admitted to a Chilean regional hospital.
Patients And Methods:
We looked for adult patients with Streptococcus pneumoniae isolated from blood cultures between 2010 and 2014 years and reviewed clinical records of those who were admitted with pneumonia.
Results:
We identified 70 BPP patients: 58% were men, mean age was 56 years, 30% were > 65 years, 70% with basic public health insurance, 26% were alcoholics, 86% had comorbidities. Only two patients were vaccinated against S. pneumoniae. CURB-65 severity index for community acquired pneumonia was > 3 in 37% of patients. Twenty-four patients were admitted to ICU, twenty required mechanical ventilation and twenty-four died (34%). Mortality was associated with an age over 65 years, presence of comorbidities and complications of pneumonia. A total of 22 serotypes of S. pneumoniae were identified, five of them (1,3,7F,14 y 9V) were present in 57% of cases.
Conclusions:
Elevated mortality of our BNN patients was associated with comorbidities and possibly with socio economic factors, which conditioned a late access to medical care.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
04:32Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
Published on: June 28, 2018
Related Concept Videos
Hospitals-II
Nurses that work in...
Hospitals-I
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
What is an Experiment?